Bernardi et al. used PEGylated interleukin-13 receptor-alpha 2 antibody-tagged gold-silica nanoshells (PEG-IL13Rα2-AuNS) as PTT strategy against U373 and U87 MG glioma cells (28). The gene discussed is IL13RA2; the disease is central nervous system cancer.